CLOV insider filings
CLOVER HEALTH INVESTMENTS, CORP. /DE — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen CLOV transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 23 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 17 filings by 6 insiders — 839,552 shares, $3,798,293 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 300,000 shares @ $4.72 ($1,416,000) by Wai Conrad, filed 2026-09-16.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Toy Andrew — Chief Executive Officer, Director | 2 | — | 2 legs · 380,982 sh · $1,626,781 | — |
| Wai Conrad — CEO, Counterpart Health | 2 | — | 2 legs · 323,627 sh · $1,526,574 | — |
| Reynoso Jamie L. — CEO, Medicare Advantage | 6 | — | 6 legs · 44,289 sh · $204,496 | — |
| Soares Karen — Chief Legal Officer | 3 | — | 3 legs · 40,794 sh · $191,215 | — |
| THORNTON JOSEPH CLAY — Chief Financial Officer | 3 | — | 2 legs · 26,690 sh · $131,318 | 1 |
| OLDAKOWSKI JOSEPH FRANK — Chief Accounting Officer | 3 | — | 2 legs · 23,170 sh · $117,909 | 1 |
| Miller Brian James — Director | 2 | — | — | 1 |
| Torricelli Robert G — Director | 2 | — | — | 1 |
Recent insider filings — CLOVER HEALTH INVESTMENTS, CORP. /DE
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | THORNTON JOSEPH CLAY — Chief Financial Officer | Sale (S): 22,099 @ $4.97 | EDGAR |
| 2026-11-06 | 4 | OLDAKOWSKI JOSEPH FRANK — Chief Accounting Officer | Grant/award (A): 186,403 @ $0 | EDGAR |
| 2026-11-06 | 4 | THORNTON JOSEPH CLAY — Chief Financial Officer | Grant/award (A): 328,947 @ $0 | EDGAR |
| 2026-10-20 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 19,275 @ $4.66 | EDGAR |
| 2026-10-20 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 4,066 @ $4.41 | EDGAR |
| 2026-10-19 | 4 | Toy Andrew — Chief Executive Officer, Director | Sale (S): 62,176 @ $4.68 | EDGAR |
| 2026-10-19 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 14,673 @ $4.68 | EDGAR |
| 2026-10-19 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Sale (S): 4,591 @ $4.68 | EDGAR |
| 2026-10-19 | 4 | Wai Conrad — CEO, Counterpart Health | Sale (S): 23,627 @ $4.68 | EDGAR |
| 2026-10-19 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 18,273 @ $4.68 | EDGAR |
| 2026-10-07 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 2,006 @ $4.63 | EDGAR |
| 2026-10-05 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 8,750 @ $4.42 | EDGAR |
| 2026-10-02 | 4 | Torricelli Robert G — Director | Grant/award (A): 12,481 @ $0 | EDGAR |
| 2026-10-02 | 4 | Miller Brian James — Director | Grant/award (A): 12,481 @ $0 | EDGAR |
| 2026-10-02 | 4 | Toy Andrew — Chief Executive Officer, Director | Sale (S): 318,806 @ $4.19 | EDGAR |
| 2026-10-01 | 3 | Torricelli Robert G — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-01 | 3 | Miller Brian James — Director | Holdings only — no transactions reported | EDGAR |
| 2026-09-18 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 1,921 @ $4.56 | EDGAR |
| 2026-09-17 | 4 | OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLER | Sale (S): 3,170 @ $4.64 | EDGAR |
| 2026-09-16 | 4 | Wai Conrad — CEO, Counterpart Health | Sale (S): 300,000 @ $4.72 | EDGAR |
| 2026-09-15 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 6,846 @ $4.78 | EDGAR |
| 2026-09-15 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 9,273 @ $4.78 | EDGAR |
| 2026-09-14 | 4 | OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLER | Sale (S): 20,000 @ $5.16 | EDGAR |
| 2026-08-17 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Sale (S): 17,775 @ $4.39 | EDGAR |
| 2026-08-13 | 4 | Soares Karen — Chief Legal Officer | Grant/award (A): 108,695 @ $0 | EDGAR |
| 2026-08-13 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Grant/award (A): 54,347 @ $0 | EDGAR |
| 2026-08-10 | 4 | Toy Andrew — Chief Executive Officer, Director | Sale (S): 87,798 @ $4.65 | EDGAR |
| 2026-07-20 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 51,700 @ $4.51 | EDGAR |
| 2026-07-17 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 4,839 @ $4.53 | EDGAR |
| 2026-07-16 | 4 | Toy Andrew — Chief Executive Officer, Director | Sale (S): 62,711 @ $4.67 | EDGAR |
| 2026-07-16 | 4 | Wai Conrad — CEO, Counterpart Health | Sale (S): 24,215 @ $4.67 | EDGAR |
| 2026-07-16 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 13,119 @ $4.67 | EDGAR |
| 2026-07-16 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 10,519 @ $4.67 | EDGAR |
| 2026-07-16 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Sale (S): 4,630 @ $4.67 | EDGAR |
| 2026-07-09 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 2,384 @ $4.68 | EDGAR |
| 2026-07-06 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 6,229 @ $5.26 | EDGAR |
| 2026-07-01 | 4 | Toy Andrew — Chief Executive Officer, Director | Sale (S): 313,476 @ $5.32 | EDGAR |
| 2026-06-18 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 2,360 @ $4.78 | EDGAR |
| 2026-06-17 | 4 | OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLER | Sale (S): 12,102 @ $4.86 | EDGAR |
| 2026-06-16 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 6,350 @ $4.61 | EDGAR |
| 2026-06-16 | 4 | Soares Karen — Chief Legal Officer | Sale (S): 4,681 @ $4.61 | EDGAR |
| 2026-06-11 | 4 | Reynoso Jamie L. — CEO, Medicare Advantage | Sale (S): 7,289 @ $4.91 | EDGAR |
| 2026-05-28 | 4 | Wai Conrad — CEO, Counterpart Health | Sale (S): 220,426 @ $3.99 | EDGAR |
| 2026-05-19 | 4 | Edwards Carladenise Armbrister — Director | Sale (S): 67,160 @ $3.42 | EDGAR |
| 2026-05-18 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Tax withholding (F): 16,942 @ $3.47 | EDGAR |
| 2026-05-13 | 4 | Priest Brady Patrick — CEO of Clover Care Services | Sale (S): 98,039 @ $3.52 | EDGAR |
| 2026-05-12 | 4 | Toy Andrew — Chief Executive Officer, Director | Tax withholding (F): 85,704 @ $2.82 | EDGAR |
| 2026-04-21 | 4 | Priest Brady Patrick — CEO of Clover Care Services | Tax withholding (F): 36,113 @ $2.19 | EDGAR |
| 2026-04-16 | 4 | Toy Andrew — Chief Executive Officer, Director | Tax withholding (F): 60,765 @ $2.04 | EDGAR |
| 2026-04-16 | 4 | THORNTON JOSEPH CLAY — Interim CFO | Tax withholding (F): 4,158 @ $2.04 | EDGAR |
Recent 8-K events — CLOVER HEALTH INVESTMENTS, CORP. /DE
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-25 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CLOV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs